Insider Selling: Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) COO Sells $503,225.75 in Stock

Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) COO Michael Manelis sold 7,825 shares of the company’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $64.31, for a total transaction of $503,225.75. Following the transaction, the chief operating officer owned 44,713 shares in the company, valued at approximately $2,875,493.03. This trade represents a 14.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Vivmark Residential Common Shares of Beneficial Interest Price Performance

Shares of VMRK traded up $0.38 during mid-day trading on Wednesday, hitting $64.41. 6,131,899 shares of the company traded hands, compared to its average volume of 4,406,111. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.19 and a quick ratio of 0.19. The stock has a market capitalization of $24.15 billion, a P/E ratio of 15.77, a price-to-earnings-growth ratio of 5.37 and a beta of 0.73. Vivmark Residential Common Shares of Beneficial Interest has a one year low of $57.57 and a one year high of $71.50.

Trending Headlines about Vivmark Residential Common Shares of Beneficial Interest

Here are the key news stories impacting Vivmark Residential Common Shares of Beneficial Interest this week:

• Positive Sentiment: Stifel Nicolaus maintained a “buy” rating and trimmed its price target only slightly, from $79.00 to $78.50. The target remains well above the recent trading level, signaling continued confidence in Vivmark’s potential. Benzinga article
• Positive Sentiment: Evercore initiated coverage with an “in-line” rating and a $72.00 price target. Although not an outright bullish rating, the target indicates potential appreciation and adds institutional research coverage. Tickerreport article
• Positive Sentiment: Zacks Research raised its FY2026 EPS forecast from $4.06 to $4.07, FY2027 EPS from $4.20 to $4.21, and Q1 2027 EPS from $1.00 to $1.02. These increases suggest slightly improved expectations for near- and medium-term profitability.
• Neutral Sentiment: The analyst consensus still projects steady earnings progression, including approximately $4.40 in FY2028 EPS, but the revisions are small and do not represent a major change to Vivmark’s outlook.
• Negative Sentiment: Zacks lowered estimates for Q3 2026, Q2 2027, Q3 2027, Q1 2028, and FY2028. The FY2028 forecast declined from $4.43 to $4.40, indicating modest pressure on longer-term earnings expectations.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on VMRK shares. Stifel Nicolaus dropped their price objective on Vivmark Residential Common Shares of Beneficial Interest from $79.00 to $78.50 and set a “buy” rating for the company in a report on Wednesday. Evercore assumed coverage on shares of Vivmark Residential Common Shares of Beneficial Interest in a report on Tuesday. They issued an “in-line” rating and a $72.00 price objective on the stock. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $75.25.

About Vivmark Residential Common Shares of Beneficial Interest

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.